Breaking News

Hanson of Delevan appointed to Cattaraugus Co. Legislature, replacing Brisky

KELLEN M. QUIGLEY kquigley@oleantimesherald.com

August 28, 2025

LITTLE VALLEY — Brenda Hanson, a teacher from Delevan, has been appointed to the Cattaraugus County Legislature to represent District 2, filling the v...

{"newsletter-daily-headlines":"Daily Headlines", "newsletters":"Newsletters", "to-print":"To Print", "website":"Website"}

Home Online Features Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist

Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist

Press Releases

Ascletis Pharma Inc.

March 31, 2025

Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist

-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supporting once monthly or less frequent administration.

{"website":"Website"}

Olean Times Herald